Cite

    Massimiliano Gennaro et al.. “Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.” European journal of surgical oncology, vol. 47, no. 7, 2021, pp. 1606–1610. http://access.bl.uk/ark:/81055/vdc_100132804718.0x00002f